Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Metabolic Implications of Diet and Energy Intake during Physical Inactivity.

Winn NC, Pettit-Mee R, Walsh LK, Restaino RM, Ready ST, Padilla J, Kanaley JA.

Med Sci Sports Exerc. 2019 May;51(5):995-1005. doi: 10.1249/MSS.0000000000001892.

PMID:
30694977
2.

Challenges of service coordination for evacuees of Hurricane Maria through the National Disaster Medical System.

Vora NM, Grober A, Goodwin BP, Davis MS, McGee C, Luckhaupt SE, Cockrill JA, Ready S, Bluemle LN, Brewer L, Brown A, Brown C, Clement J, Downie DL, Garner MR, Lerner R, Mahool M, Mojica SA, Nolen LD, Pedersen MR, Chappell-Reed MJ, Richards E, Smith J, Weekes KC, Dickinson J, Weir C, Bowman TI, Eckes J.

J Emerg Manag. 2018 May/Jun;16(3):203-206. doi: 10.5055/jem.2018.0369.

PMID:
30044493
3.

Essential Medications for Patients With Suspected or Confirmed Ebola Virus Disease in Resource-Limited Environments.

Pierce WF, Ready SD, Chapman JT, Kulick C, Shields A, Wang J, Andrews K, Childs RW, Bell C, Kosyak A, Pham J.

Mil Med. 2017 Sep;182(9):e2006-e2016. doi: 10.7205/MILMED-D-17-00010.

4.

Retinal amino acid neurochemistry of the southern hemisphere lamprey, Geotria australis.

Nivison-Smith L, Collin SP, Zhu Y, Ready S, Acosta ML, Hunt DM, Potter IC, Kalloniatis M.

PLoS One. 2013;8(3):e58406. doi: 10.1371/journal.pone.0058406. Epub 2013 Mar 13. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/99baec7f-908c-4e88-8a87-a25f2aa1630c.

5.

Recombinant strains for the enhanced production of bioengineered rapalogs.

Kendrew SG, Petkovic H, Gaisser S, Ready SJ, Gregory MA, Coates NJ, Nur-E-Alam M, Warneck T, Suthar D, Foster TA, McDonald L, Schlingman G, Koehn FE, Skotnicki JS, Carter GT, Moss SJ, Zhang MQ, Martin CJ, Sheridan RM, Wilkinson B.

Metab Eng. 2013 Jan;15:167-73. doi: 10.1016/j.ymben.2012.11.001. Epub 2012 Nov 17.

PMID:
23164580
6.

Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureas.

Oza V, Ashwell S, Almeida L, Brassil P, Breed J, Deng C, Gero T, Grondine M, Horn C, Ioannidis S, Liu D, Lyne P, Newcombe N, Pass M, Read J, Ready S, Rowsell S, Su M, Toader D, Vasbinder M, Yu D, Yu Y, Xue Y, Zabludoff S, Janetka J.

J Med Chem. 2012 Jun 14;55(11):5130-42. doi: 10.1021/jm300025r. Epub 2012 Jun 4.

PMID:
22551018
7.

Retinal metabolic state of the proline-23-histidine rat model of retinitis pigmentosa.

Acosta ML, Shin YS, Ready S, Fletcher EL, Christie DL, Kalloniatis M.

Am J Physiol Cell Physiol. 2010 Mar;298(3):C764-74. doi: 10.1152/ajpcell.00253.2009. Epub 2009 Dec 23.

8.

Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Bruckheimer EM, Fazenbaker CA, Gallagher S, Mulgrew K, Fuhrmann S, Coffman KT, Walsh W, Ready S, Cook K, Damschroder M, Kinch M, Kiener PA, Woods R, Gao C, Dall'Acqua W, Wu H, Coats S.

Neoplasia. 2009 Jun;11(6):509-17, 2 p following 517.

9.

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.

Zabludoff SD, Deng C, Grondine MR, Sheehy AM, Ashwell S, Caleb BL, Green S, Haye HR, Horn CL, Janetka JW, Liu D, Mouchet E, Ready S, Rosenthal JL, Queva C, Schwartz GK, Taylor KJ, Tse AN, Walker GE, White AM.

Mol Cancer Ther. 2008 Sep;7(9):2955-66. doi: 10.1158/1535-7163.MCT-08-0492.

10.
11.

Characterization of a 3;6 translocation associated with renal cell carcinoma.

Foster RE, Abdulrahman M, Morris MR, Prigmore E, Gribble S, Ng B, Gentle D, Ready S, Weston PM, Wiesener MS, Kishida T, Yao M, Davison V, Barbero JL, Chu C, Carter NP, Latif F, Maher ER.

Genes Chromosomes Cancer. 2007 Apr;46(4):311-7.

12.

Rapamycin biosynthesis: Elucidation of gene product function.

Gregory MA, Hong H, Lill RE, Gaisser S, Petkovic H, Low L, Sheehan LS, Carletti I, Ready SJ, Ward MJ, Kaja AL, Weston AJ, Challis IR, Leadlay PF, Martin CJ, Wilkinson B, Sheridan RM.

Org Biomol Chem. 2006 Oct 7;4(19):3565-8. Epub 2006 Aug 22.

PMID:
16990929
13.

Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo.

Ulbrandt ND, Ji H, Patel NK, Riggs JM, Brewah YA, Ready S, Donacki NE, Folliot K, Barnes AS, Senthil K, Wilson S, Chen M, Clarke L, MacPhail M, Li J, Woods RM, Coelingh K, Reed JL, McCarthy MP, Pfarr DS, Osterhaus AD, Fouchier RA, Kiener PA, Suzich JA.

J Virol. 2006 Aug;80(16):7799-806.

14.

Vertically integrated thin film color sensor arrays for imaging applications.

Knipp D, Street RA, Stiebig H, Krause M, Lu JP, Ready S, Ho J.

Opt Express. 2006 Apr 17;14(8):3106-13.

PMID:
19516452
15.

Oxidized lipids as mediators of coronary heart disease.

Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM.

Curr Opin Lipidol. 2002 Aug;13(4):363-72. Review. Erratum in: Curr Opin Lipidol. 2002 Oct;13(5):589. Ready Srinu T [corrected to Reddy Srinu T].

PMID:
12151851
16.

Engineered biosynthesis of novel spinosyns bearing altered deoxyhexose substituents.

Gaisser S, Martin CJ, Wilkinson B, Sheridan RM, Lill RE, Weston AJ, Ready SJ, Waldron C, Crouse GD, Leadlay PF, Staunton J.

Chem Commun (Camb). 2002 Mar 21;(6):618-9.

PMID:
12120151
17.

SB-253514 and analogues; novel inhibitors of lipoprotein-associated phospholipase A2 produced by Pseudomonas fluorescens DSM 11579. I. Fermentation of producing strain, isolation and biological activity.

Thirkettle J, Alvarez E, Boyd H, Brown M, Diez E, Hueso J, Elson S, Fulston M, Gershater C, Morata ML, Perez P, Ready S, Sanchez-Puelles JM, Sheridan R, Stefanska A, Warr S.

J Antibiot (Tokyo). 2000 Jul;53(7):664-9.

18.
19.

SB-219383, a novel tyrosyl tRNA synthetase inhibitor from a Micromonospora sp. I. Fermentation, isolation and properties.

Stefanska AL, Coates NJ, Mensah LM, Pope AJ, Ready SJ, Warr SR.

J Antibiot (Tokyo). 2000 Apr;53(4):345-50.

20.

Local bonding structure of deuterium in single-crystal silicon determined by nuclear magnetic resonance.

Boyce JB, Johnson NM, Ready SE, Walker J.

Phys Rev B Condens Matter. 1992 Aug 15;46(7):4308-4311. No abstract available.

PMID:
10004174
21.

Nuclear-magnetic-double-resonance investigation of the dopant microstructure in hydrogenated amorphous silicon.

Boyce JB, Ready SE.

Phys Rev B Condens Matter. 1988 Dec 1;38(16):11008-11018. No abstract available.

PMID:
9945974
22.

Two-level systems in hydrogenated amorphous silicon: NMR studies.

Boyce JB, Stutzmann M, Ready SE.

Phys Rev B Condens Matter. 1985 Nov 1;32(9):6062-6065. No abstract available.

PMID:
9937858

Supplemental Content

Support Center